Risk Off Resumes With Profit Taking-Biotechs Off 5% From Highs
Biotech Sector Momentum Quits-IBB at Support Level of $189 NASDAQ Off 1.73% to 3605 Have fund managers raised cash and gone on vacation? Moreover many weaker sectors have become leaders like gold, silver,materials and energy. Walmart and Cisco are leading the way down against a back drop of...
Rayno Life Science Portfolio: ILMN, PCYC, RGDX
Market Can't Stay Down in Quiet Trading After a couple of lackluster trading days the market perked up as economic news continues positive with retail sales up for the fourth consecutive month and many analysts believing Europe is coming out of recession. And the Icahn effect is back as Carl...
Mixed Day Except Intrexon (XON) IPO Soars 54%
Intrexon (XON), a synthetic biology Company, focused in healthcare, animal science and agriculture raised over $160M in a Huge IPO . CEO Randall Kirk purchased 30M shares. Some pundits say this event punctuates the "golden age of biology". This is the third successful Company for billionaire...
AACC Brief #2 Issues Arising-Reimbursement and Lab Developed Tests
The 2013 AACC (American Association for Clinical Chemistry) Meeting was attended by 650 exhibitors and over 17,000 professionals all looking to connect in the In Vitro Diagnostics (IVD) industry. For a complete up-to-date news and analysis of the industry check IVDNews. In this brief we will...
Profit Taking in Biotech Triggered by Regeneron (REGN) Miss Update 5p
Weakness in NASDAQ and Earnings Miss Gives an Excuse To Sell The Blistering 14% July Run in Biotech Comes to an End It was inevitable that something would cause biopharmaceutical stocks to falter. Today it was overall weakness in the market and a miss by the highest of high fliers Regeneron...